Last updated
Europe Medical Cannabis Market 2024-2032
According to IMARC Group's report titled "Europe Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivative (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End Use (Pharmaceutical Industry, Research and Development Centers, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), and Country 2024-2032", The market reached USD 2,167.8 Million in 2023. Looking forward, IMARC Group expects the market to reach USD 11,093.7 Million by 2032, exhibiting a growth rate (CAGR) of 19.3% during 2024-2032. The market in Europe is majorly driven by the increasing legalization and regulatory acceptance of medical cannabis across various European countries.
Governments are recognizing the therapeutic potential of cannabis in treating a range of medical conditions, including chronic pain, epilepsy, multiple sclerosis, and cancer-related symptoms. This shift in legal frameworks is paving the way for a more structured and regulated market, enabling patients to access medical cannabis under medical supervision. Another crucial factor is the growing body of clinical evidence supporting the efficacy of medical cannabis. Research and clinical trials demonstrating the benefits of cannabis-based treatments are gaining traction, leading to greater acceptance among healthcare professionals.
Europe Medical Cannabis Market Scope and Growth Analysis:
The Europe medical cannabis market is diverse, encompassing a range of products, including oils, tinctures, capsules, and dried cannabis flowers. The market is segmented by product type, application, and distribution channel. Oils and tinctures are among the most popular product types due to their ease of use and precise dosing capabilities. The market is also segmented by medical conditions treated, with chronic pain, anxiety, and epilepsy being the primary applications. Market analysis reveals a dynamic landscape with a mix of domestic and international players. Companies are expanding their presence in the European market through partnerships, mergers, and acquisitions. These companies are focusing on scaling up production, improving product quality, and complying with stringent European regulatory standards.
The establishment of Good Manufacturing Practice (GMP)-certified production facilities in Europe is a key trend, ensuring that medical cannabis products meet high safety and quality standards. The Europe medical cannabis market demand is also influenced by trends such as the increasing focus on research and development (R&D) and the emergence of cannabis-derived pharmaceuticals. As R&D efforts intensify, new formulations and delivery methods are being developed to cater to specific medical needs. Additionally, the expansion of medical cannabis programs across Europe is creating opportunities for growth in both established and emerging markets. Countries like Germany, Italy, and the United Kingdom are leading in terms of market size, but other countries are also opening up to medical cannabis, contributing to the overall market expansion.
Request Free Sample Report: https://www.imarcgroup.com/europe-medical-cannabis-market/requestsample
Europe Medical Cannabis Industry Segmentation:
The report has segmented the market into the following categories:
Breakup by Species:
Indica
Sativa
Hybrid
Breakup by Derivative:
Cannabidiol (CBD)
Tetrahydrocannabinol (THC)
Others
Breakup by Application:
Cancer
Arthritis
Migraine
Epilepsy
Others
Breakup by End Use:
Pharmaceutical Industry
Research and Development Centers
Others
Breakup by Route of Administration:
Oral Solutions and Capsules
Smoking
Vaporizers
Topicals
Others
Breakup by Country:
Germany
France
United Kingdom
Italy
Spain
Others
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Ask Analyst For Customization: https://www.imarcgroup.com/request?type=report&id=3059&flag=C
Other key areas covered in the report:
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Market Dynamics
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Top Winning Strategies
Recent Industry News
Key Technological Trends & Development
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us: IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
